CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Other acquisition Director acquired 89,571 shares (other)
- 4 Exercise or conversion Director acquired 215,600 shares (option exercise)
- 4 Open-market buy Director bought 4,500 shares at $2.16 ($9,720)
- 4 Grant or award Pieper Steven acquired 450,000 shares (grant or award)
- 4 Grant or award Shannon John Patrick Jr acquired 750,000 shares (grant or award)
- 4 Grant or award JOHNSON KENNETH ERLAND acquired 175,000 shares (grant or award)
- 4 Grant or award Hecht Beth acquired 750,000 shares (grant or award)
- 4 Grant or award Edick Paul R acquired 1,500,000 shares (grant or award)
- 4 Open-market buy Director bought 5,400 shares at $1.87 ($10,098)
- 4 Open-market buy Director bought 5,410 shares at $1.84 ($9,954)
- 4 Open-market buy Pieper Steven bought 28,000 shares at $1.95 ($54,600)
- 4 Open-market buy Director bought 6,500 shares at $1.51 ($9,815)
- 4 Open-market buy Shannon John Patrick Jr bought 30,769 shares at $1.64 ($50,400)
- 4 Open-market buy Director bought 6,370 shares at $1.58 ($10,058)
- 4 Open-market buy Edick Paul R bought 10,000 shares at $2.38 ($23,794)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
Page 6 of 9 · 178 filings